Triosephosphate Isomerase Inhibition by Resveratrol: A New Mechanism of Anti-Glycolysis in Breast Cancer
-
Published:2024-09-11
Issue:
Volume:
Page:
-
ISSN:0026-8933
-
Container-title:Molecular Biology
-
language:en
-
Short-container-title:Mol Biol
Author:
Tuna G.ORCID,
Akgün O.ORCID,
Arı F.ORCID
Publisher
Pleiades Publishing Ltd
Reference48 articles.
1. Ashraf M.A. 2020. Phytochemicals as potential anticancer drugs: Time to ponder nature’s bounty. Biomed. Res. Int. 2020, 8602879.
2. World Health Organization. 2022. Cancer. https:// www.who.int/news-room/fact-sheets/detail/cancer. Accessed October 10, 2023.
3. Newman D.J., Cragg G.M. 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311–335.
4. Catalgol B., Batirel S., Taga Y., Ozer N.K. 2012. Resveratrol: french paradox revisited. Front. Pharmacol. 3, 141.
5. Gomez L.S., Zancan P., Marcondes M.C., Ramos-Santos L., Meyer-Fernandes J.R., Sola-Penna M., da Silva D. 2013. Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie. 95, 1336–1343.